Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Screening for Musculoskeletal Impairments and Quality of Life in Individuals Post-Treatment for Breast Cancer

NCT02370264 is registered in ClinicalTrials.gov with University of Southern California as lead sponsor.

NCT NCT02370264
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02370264 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Screening for Musculoskeletal Impairments and Quality of Life in Individuals Post-Treatment for Breast Cancer
Lead sponsor
University of Southern California
Phase
Not applicable
Overall status
Terminated
Start date
October 1, 2012
Completion date
October 21, 2016
Enrollment
36 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

musculoskeletal complication, recurrent breast carcinoma, stage ia breast cancer, stage ib breast cancer, stage iia breast cancer, stage iib breast cancer, stage iiia breast cancer, stage iiib breast cancer, stage iiic breast cancer, stage iv breast cancer, therapy-related toxicity